Literature DB >> 1233233

Kinetics of nortriptyline in man according to a two compartment model.

K F Overo, L F Gram, V Hansen.   

Abstract

Plasma concentrations of nortriptyline have been assayed in four subjects after intravenous infusion of 57 mg nortriptyline hydrochloride. The data were evaluated according to a two compartment open model. The calculated best-fitting curves were in good agreement with the experimental data, better than could be expected from a simpler model. This justifies the assumption that the kinetics of nortriptyline in man may be described by this model with an appropriate input function. The data permitted estimation of all the parameters of the model. The meaning of the parameters is discussed, particularly in relation to individual variation.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1233233     DOI: 10.1007/bf00562660

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  7 in total

1.  Application of isotope derivative technique to assay of secondary amines: estimation of desipramine by acetylation with H3-acetic anhydride.

Authors:  W M Hammer; B B Brodiet
Journal:  J Pharmacol Exp Ther       Date:  1967-09       Impact factor: 4.030

2.  Increased specificity of the 3 H-acetic anhydride coupling method for plasma analysis of drugs containing secondary amino groups.

Authors:  K F Overo
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1972

3.  Pharmacokinetics of nortriptyline in man after single and multiple oral doses: the predictability of steady-state plasma concentrations from single-dose plasma-level data.

Authors:  B Alexanderson
Journal:  Eur J Clin Pharmacol       Date:  1972-03       Impact factor: 2.953

4.  General treatment of linear mammillary models with elimination from any compartment as used in pharmacokinetics.

Authors:  L Z Benet
Journal:  J Pharm Sci       Date:  1972-04       Impact factor: 3.534

5.  Integral coefficients of multi-compartment pharmacokinetic models. Application to chemotherapy.

Authors:  W J Jusko; G P Lewis; L W Dittert
Journal:  Chemotherapy       Date:  1972       Impact factor: 2.544

6.  Gas chromatography-mass spectrometry of nortriptyline in body fluids of man.

Authors:  C G Hammar; B Alexanderson; B Holmstedt; F Sjöqvist
Journal:  Clin Pharmacol Ther       Date:  1971 May-Jun       Impact factor: 6.875

7.  Plasma levels of monomethylated tricyclic antidepressants during treatment with imipramine-like compounds.

Authors:  W Hammer; F Sjöqvist
Journal:  Life Sci       Date:  1967-09-01       Impact factor: 5.037

  7 in total
  7 in total

1.  Pharmacokinetic data. Pharmacokinetic parameters estimated from intravenous data by uniform methods and some of their uses.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1977-04

Review 2.  Current antidepressant drugs: their clinical use.

Authors:  L E Hollister
Journal:  Drugs       Date:  1981-08       Impact factor: 9.546

3.  Comparison of single dose kinetics of imipramine, nortriptyline and antipyrine in man.

Authors:  L F Gram; P B Andreasen; K F Overo; J Christiansen
Journal:  Psychopharmacology (Berl)       Date:  1976-10-20       Impact factor: 4.530

4.  Pharmacokinetics of amitriptyline infused intravenously in man.

Authors:  A Jorgensen; V Hansen
Journal:  Eur J Clin Pharmacol       Date:  1976-09-30       Impact factor: 2.953

5.  Population pharmacokinetics of nortriptyline during monotherapy and during concomitant treatment with drugs that inhibit CYP2D6--an evaluation with the nonparametric maximum likelihood method.

Authors:  M Jerling; Y Merlé; F Mentré; A Mallet
Journal:  Br J Clin Pharmacol       Date:  1994-11       Impact factor: 4.335

6.  Drowsiness, impaired performance and tricyclic antidepressants drugs.

Authors:  C Bye; M Clubley; A W Peck
Journal:  Br J Clin Pharmacol       Date:  1978-08       Impact factor: 4.335

7.  Amitriptyline pharmacokinetics. A crossover study with single doses of amitriptyline and nortriptyline.

Authors:  J E Burch; R P Hullin
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.